PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, p. e0178040
Since implementation of the 13-valent polyvalent conjugate vaccine (PCV13) in Canada during 2010, the proportion of PCV13 serotypes causing invasive...
UNITED-STATES | REPLACEMENT | CONJUGATE VACCINE | MULTIDISCIPLINARY SCIENCES | ALGORITHM | RESISTANCE | WALES | MOLECULAR EPIDEMIOLOGY | ENGLAND | Genome, Bacterial | Streptococcus pneumoniae - classification | Humans | Serogroup | Drug Resistance, Bacterial | Erythromycin | Phylogeny | Canada | Streptococcus pneumoniae - isolation & purification | Molecular Typing - methods | Streptococcus pneumoniae - genetics | Pneumococcal Infections - microbiology | Polymorphism, Single Nucleotide | Sequence Analysis, DNA - methods | Drug resistance in microorganisms | Care and treatment | Pneumonia | Usage | Bacterial pneumonia | Analysis | Dosage and administration | Research | Drug therapy | Antibacterial agents | Streptococcus pneumoniae | Laboratories | Virulence | Genomes | Vaccines | Drug resistance | Epidemiology | Gene sequencing | Streptococcus infections | Penicillin | Phylogenetics | Meningitis | Bioinformatics | Age | Public health | Recombinant | Factor analysis | rRNA | rRNA 23S | Antimicrobial agents | Resistance factors | Disease control | Switching | Hospitals | Streptococcus | Surveillance | Point mutation | Serotypes | Homogeneity | Mutation | Antimicrobial resistance
UNITED-STATES | REPLACEMENT | CONJUGATE VACCINE | MULTIDISCIPLINARY SCIENCES | ALGORITHM | RESISTANCE | WALES | MOLECULAR EPIDEMIOLOGY | ENGLAND | Genome, Bacterial | Streptococcus pneumoniae - classification | Humans | Serogroup | Drug Resistance, Bacterial | Erythromycin | Phylogeny | Canada | Streptococcus pneumoniae - isolation & purification | Molecular Typing - methods | Streptococcus pneumoniae - genetics | Pneumococcal Infections - microbiology | Polymorphism, Single Nucleotide | Sequence Analysis, DNA - methods | Drug resistance in microorganisms | Care and treatment | Pneumonia | Usage | Bacterial pneumonia | Analysis | Dosage and administration | Research | Drug therapy | Antibacterial agents | Streptococcus pneumoniae | Laboratories | Virulence | Genomes | Vaccines | Drug resistance | Epidemiology | Gene sequencing | Streptococcus infections | Penicillin | Phylogenetics | Meningitis | Bioinformatics | Age | Public health | Recombinant | Factor analysis | rRNA | rRNA 23S | Antimicrobial agents | Resistance factors | Disease control | Switching | Hospitals | Streptococcus | Surveillance | Point mutation | Serotypes | Homogeneity | Mutation | Antimicrobial resistance
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2019, Volume 14, Issue 3, p. e0214228
Campylobacter transducer-like proteins (Tlps), also known as methyl-accepting chemotaxis proteins (MCPs), are associated with virulence as well as niche and...
STRAINS | DOMAIN | ALIGNMENT | COMPARATIVE GENOMICS | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ASPARTATE CHEMOSENSORY RECEPTOR | MECHANISMS | VIRULENCE | BURDEN | JEJUNI CHEMOTAXIS | Proteins | Genetic aspects | Genomes | Cellular signal transduction | Research | Genomics | Repositories | Guillain-Barre syndrome | Laboratories | Poultry | Genes | Virulence | Inversion | Signal transduction | Heterogeneity | Databases | E coli | Species | Public health | Deoxyribonucleic acid--DNA | Campylobacter | Food contamination & poisoning | Fetuses | Nomenclature | Mammals | Chemotaxis | Substrates | Ligands | Transduction | Chemoreceptors | Niches | Deoxyribonucleic acid | DNA
STRAINS | DOMAIN | ALIGNMENT | COMPARATIVE GENOMICS | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ASPARTATE CHEMOSENSORY RECEPTOR | MECHANISMS | VIRULENCE | BURDEN | JEJUNI CHEMOTAXIS | Proteins | Genetic aspects | Genomes | Cellular signal transduction | Research | Genomics | Repositories | Guillain-Barre syndrome | Laboratories | Poultry | Genes | Virulence | Inversion | Signal transduction | Heterogeneity | Databases | E coli | Species | Public health | Deoxyribonucleic acid--DNA | Campylobacter | Food contamination & poisoning | Fetuses | Nomenclature | Mammals | Chemotaxis | Substrates | Ligands | Transduction | Chemoreceptors | Niches | Deoxyribonucleic acid | DNA
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 6, pp. 846 - 853
Abstract Background Pneumococcal disease burden is difficult to quantify due to limited data regarding non-bacteremic disease. We assessed serotype-specific...
Allergy and Immunology | Invasive pneumococcal disease | Pneumonia | Serotype | Pneumococcal vaccine | MEDICINE, RESEARCH & EXPERIMENTAL | COMMUNITY-ACQUIRED PNEUMONIA | RISK-FACTORS | CONJUGATE VACCINE | STREPTOCOCCUS-PNEUMONIAE SEROTYPE | ADULTS | PREVALENCE | IMMUNOLOGY | 13-VALENT | IMMUNOGENICITY | DISEASE | GREATER-THAN-OR-EQUAL-TO-50 YEARS | Streptococcus pneumoniae - classification | Humans | Middle Aged | Serogroup | Male | Pneumonia, Bacterial - epidemiology | Young Adult | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Adolescent | Ontario - epidemiology | Aged, 80 and over | Adult | Bacteremia - epidemiology | Female | Aged | Population Surveillance | Vaccines | Laboratories | Mortality | Respiratory diseases
Allergy and Immunology | Invasive pneumococcal disease | Pneumonia | Serotype | Pneumococcal vaccine | MEDICINE, RESEARCH & EXPERIMENTAL | COMMUNITY-ACQUIRED PNEUMONIA | RISK-FACTORS | CONJUGATE VACCINE | STREPTOCOCCUS-PNEUMONIAE SEROTYPE | ADULTS | PREVALENCE | IMMUNOLOGY | 13-VALENT | IMMUNOGENICITY | DISEASE | GREATER-THAN-OR-EQUAL-TO-50 YEARS | Streptococcus pneumoniae - classification | Humans | Middle Aged | Serogroup | Male | Pneumonia, Bacterial - epidemiology | Young Adult | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Adolescent | Ontario - epidemiology | Aged, 80 and over | Adult | Bacteremia - epidemiology | Female | Aged | Population Surveillance | Vaccines | Laboratories | Mortality | Respiratory diseases
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 02/2018, Volume 24, Issue 2, pp. 381 - 383
We identified a ceftriaxone-resistant Neisseria gonorrhoeae isolate in a patient in Canada. This isolate carried the penA-60 allele, which differs...
INFECTIOUS DISEASES | IMMUNOLOGY | STRAIN | SUSCEPTIBILITY | JAPAN | Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Humans | Drug Resistance, Bacterial | Ceftriaxone - pharmacology | Male | Gonorrhea - drug therapy | Microbial Sensitivity Tests | Young Adult | Travel | Canada - epidemiology | Asia | Female | Anti-Bacterial Agents - pharmacology | Gonorrhea - epidemiology | Neisseria gonorrhoeae - genetics | Ceftriaxone sodium | Ceftriaxone | Complications and side effects | Azithromycin | Dosage and administration | Gonorrhea | Drug therapy | penA-60 | Canada, 2017 | bacteria | gonorrhea | Dispatch | antimicrobial susceptibility surveillance | mosaic penA allele | North America | ceftriaxone | Canada | Neisseria gonorrhoeae | sexually transmitted infections | antimicrobial resistance | Ceftriaxone-Resistant | ceftriaxone-resistant
INFECTIOUS DISEASES | IMMUNOLOGY | STRAIN | SUSCEPTIBILITY | JAPAN | Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Humans | Drug Resistance, Bacterial | Ceftriaxone - pharmacology | Male | Gonorrhea - drug therapy | Microbial Sensitivity Tests | Young Adult | Travel | Canada - epidemiology | Asia | Female | Anti-Bacterial Agents - pharmacology | Gonorrhea - epidemiology | Neisseria gonorrhoeae - genetics | Ceftriaxone sodium | Ceftriaxone | Complications and side effects | Azithromycin | Dosage and administration | Gonorrhea | Drug therapy | penA-60 | Canada, 2017 | bacteria | gonorrhea | Dispatch | antimicrobial susceptibility surveillance | mosaic penA allele | North America | ceftriaxone | Canada | Neisseria gonorrhoeae | sexually transmitted infections | antimicrobial resistance | Ceftriaxone-Resistant | ceftriaxone-resistant
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 04/2018, Volume 24, Issue 4, pp. 735 - 740
Ceftriaxone remains a first-line treatment for patients infected by Neisseria gonorrhoeae in most settings. We investigated the possible spread of a...
INFECTIOUS DISEASES | CANADA | IMMUNOLOGY | DECREASED CEPHALOSPORIN SUSCEPTIBILITY | JAPAN | Genome, Bacterial | Gonorrhea - microbiology | beta-Lactam Resistance | Neisseria gonorrhoeae - drug effects | Humans | Ceftriaxone - pharmacology | Neisseria gonorrhoeae - classification | Phylogeny | beta-Lactamase Inhibitors - pharmacology | Microbial Sensitivity Tests | Polymorphism, Single Nucleotide | Genomics - methods | Neisseria gonorrhoeae - genetics | penicillin | gentamycin | Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant | gonorrhea | Japan | spectinomycin | azithromycin | Research | β-lactam | cephalosporin | Strain | Spain | ceftriaxone | Canada | Neisseria gonorrhoeae | antimicrobial resistance | China | cefixime | tetracycline | France | Australia | penA gene | ciprofloxacin | penicillinase | Neisseria N. gonorrhoeae | gonorrhoeae
INFECTIOUS DISEASES | CANADA | IMMUNOLOGY | DECREASED CEPHALOSPORIN SUSCEPTIBILITY | JAPAN | Genome, Bacterial | Gonorrhea - microbiology | beta-Lactam Resistance | Neisseria gonorrhoeae - drug effects | Humans | Ceftriaxone - pharmacology | Neisseria gonorrhoeae - classification | Phylogeny | beta-Lactamase Inhibitors - pharmacology | Microbial Sensitivity Tests | Polymorphism, Single Nucleotide | Genomics - methods | Neisseria gonorrhoeae - genetics | penicillin | gentamycin | Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant | gonorrhea | Japan | spectinomycin | azithromycin | Research | β-lactam | cephalosporin | Strain | Spain | ceftriaxone | Canada | Neisseria gonorrhoeae | antimicrobial resistance | China | cefixime | tetracycline | France | Australia | penA gene | ciprofloxacin | penicillinase | Neisseria N. gonorrhoeae | gonorrhoeae
Journal Article
EMERGING INFECTIOUS DISEASES, ISSN 1080-6040, 09/2019, Volume 25, Issue 9, pp. 1660 - 1667
In July 2018, a case of Neisseria gonorrhoeae associated with ceftriaxone treatment failure was identified in Alberta, Canada. We identified the isolate and...
INFECTIOUS DISEASES | DECREASED SUSCEPTIBILITY | GLOBAL QUALITY-ASSURANCE | MALAWI | MARKERS | IMMUNOLOGY | ANTIMICROBIAL RESISTANCE | molecular epidemiology | bacteria | Alberta | gonorrhea | Neisseria gonorrhoeae | molecular typing | azithromycin | Research | penicillin binding protein 2 | cephalosporin | ceftriaxone | Canada | Strain, Alberta, Canada, 2018 | treatment failure | antimicrobial resistance | Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant | cefixime | drug resistance
INFECTIOUS DISEASES | DECREASED SUSCEPTIBILITY | GLOBAL QUALITY-ASSURANCE | MALAWI | MARKERS | IMMUNOLOGY | ANTIMICROBIAL RESISTANCE | molecular epidemiology | bacteria | Alberta | gonorrhea | Neisseria gonorrhoeae | molecular typing | azithromycin | Research | penicillin binding protein 2 | cephalosporin | ceftriaxone | Canada | Strain, Alberta, Canada, 2018 | treatment failure | antimicrobial resistance | Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant | cefixime | drug resistance
Journal Article
Vaccine, ISSN 0264-410X, 07/2018, Volume 36, Issue 31, pp. 4701 - 4707
The 13-valent conjugate vaccine (PCV13) was recommended for childhood immunization programs in 2010 in Canada and has decreased the incidence of invasive...
Pneumococcal conjugate vaccine | Herd immunity | Surveillance | Invasive pneumococcal disease | Adults | Serotype | Antimicrobial resistance | Pneumococcus | Streptococcus pneumoniae | MEDICINE, RESEARCH & EXPERIMENTAL | INFECTIONS | OLDER-ADULTS | IMMUNOLOGY | CHILDREN | CHANGING EPIDEMIOLOGY | IMMUNIZATION | RECOMMENDATIONS | DISEASE | 19A | POLYSACCHARIDE VACCINE | Streptococcus pneumoniae - classification | Humans | Serogroup | Drug Resistance, Bacterial | Immunity, Herd | Male | Pneumococcal Vaccines - administration & dosage | Incidence | Microbial Sensitivity Tests | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Canada - epidemiology | Aged, 80 and over | Female | Pneumococcal Infections - microbiology | Aged | Anti-Bacterial Agents - pharmacology | Serotyping | Drug resistance in microorganisms | Pneumonia | Epidemiology | Bacterial pneumonia | Vaccination | Clarithromycin | Disease | Laboratories | Clindamycin | Trimethoprim | Antisera | Vaccines | Ceftriaxone | Drug resistance | Antiinfectives and antibacterials | Immunity | Streptococcus infections | Cefuroxime | Trimethoprim-sulfamethoxazole | Polysaccharides | Sulfamethoxazole | Older people | Penicillin | Meningitis | Children | Age | Public health | Immunization | Antimicrobial agents | RNA polymerase | Doxycycline | Serotypes
Pneumococcal conjugate vaccine | Herd immunity | Surveillance | Invasive pneumococcal disease | Adults | Serotype | Antimicrobial resistance | Pneumococcus | Streptococcus pneumoniae | MEDICINE, RESEARCH & EXPERIMENTAL | INFECTIONS | OLDER-ADULTS | IMMUNOLOGY | CHILDREN | CHANGING EPIDEMIOLOGY | IMMUNIZATION | RECOMMENDATIONS | DISEASE | 19A | POLYSACCHARIDE VACCINE | Streptococcus pneumoniae - classification | Humans | Serogroup | Drug Resistance, Bacterial | Immunity, Herd | Male | Pneumococcal Vaccines - administration & dosage | Incidence | Microbial Sensitivity Tests | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Canada - epidemiology | Aged, 80 and over | Female | Pneumococcal Infections - microbiology | Aged | Anti-Bacterial Agents - pharmacology | Serotyping | Drug resistance in microorganisms | Pneumonia | Epidemiology | Bacterial pneumonia | Vaccination | Clarithromycin | Disease | Laboratories | Clindamycin | Trimethoprim | Antisera | Vaccines | Ceftriaxone | Drug resistance | Antiinfectives and antibacterials | Immunity | Streptococcus infections | Cefuroxime | Trimethoprim-sulfamethoxazole | Polysaccharides | Sulfamethoxazole | Older people | Penicillin | Meningitis | Children | Age | Public health | Immunization | Antimicrobial agents | RNA polymerase | Doxycycline | Serotypes
Journal Article
BMC genomics, ISSN 1471-2164, 03/2019, Volume 20, Issue 1, pp. 165 - 11
Recent adva1nces in whole genome sequencing (WGS) based technologies have facilitated multi-step applications for predicting antimicrobial resistance (AMR) and...
Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Gonorrhea - genetics | Humans | Anti-Infective Agents - therapeutic use | Whole Genome Sequencing - methods | Multilocus Sequence Typing | Gonorrhea - drug therapy | Genome, Bacterial - genetics | Molecular Epidemiology | Anti-Infective Agents - chemistry | Drug Resistance, Bacterial - genetics | Neisseria gonorrhoeae - genetics | Neisseria gonorrhoeae - pathogenicity | Microbial Sensitivity Tests - methods | Molecular typing | CANADA | Whole-genome sequencing (WGS) | Strain typing | De novo genome assembly | Neisseria gonorrhoeae | ALIGNMENT | Scaffolding | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | Molecular epidemiology | RESISTANCE | Antimicrobial resistance | Bioinformatics | TOOL | Drug resistance in microorganisms | Genetic aspects | Nucleotide sequencing | Health aspects | Methods | DNA sequencing | Automation | Pipelines | Genes | Nomenclature | Antimicrobial agents | Genomes | Statistical methods | Drug resistance | Epidemiology | Antiinfectives and antibacterials | Data bases | Computer programs | Gene sequencing | Plasmids | Conditioned stimulus | Determinants | Software | Assemblies | Females | Chromosomes | Scaffolds
Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Gonorrhea - genetics | Humans | Anti-Infective Agents - therapeutic use | Whole Genome Sequencing - methods | Multilocus Sequence Typing | Gonorrhea - drug therapy | Genome, Bacterial - genetics | Molecular Epidemiology | Anti-Infective Agents - chemistry | Drug Resistance, Bacterial - genetics | Neisseria gonorrhoeae - genetics | Neisseria gonorrhoeae - pathogenicity | Microbial Sensitivity Tests - methods | Molecular typing | CANADA | Whole-genome sequencing (WGS) | Strain typing | De novo genome assembly | Neisseria gonorrhoeae | ALIGNMENT | Scaffolding | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | Molecular epidemiology | RESISTANCE | Antimicrobial resistance | Bioinformatics | TOOL | Drug resistance in microorganisms | Genetic aspects | Nucleotide sequencing | Health aspects | Methods | DNA sequencing | Automation | Pipelines | Genes | Nomenclature | Antimicrobial agents | Genomes | Statistical methods | Drug resistance | Epidemiology | Antiinfectives and antibacterials | Data bases | Computer programs | Gene sequencing | Plasmids | Conditioned stimulus | Determinants | Software | Assemblies | Females | Chromosomes | Scaffolds
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2017, Volume 65, Issue 1, pp. 37 - 45
Background. Increasing azithromycin usage and resistance in Neisseria gonorrhoeae threatens current dual treatment. Because antimicrobial exposure influences...
Usage | Neisseria gonorrhoeae | Gonorrhea | Research | Risk factors | Azithromycin
Usage | Neisseria gonorrhoeae | Gonorrhea | Research | Risk factors | Azithromycin
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 01/2010, Volume 16, Issue 1, pp. 48 - 54
The Canadian Integrated Program for Antimicrobial Resistance Surveillance describes a strong correlation (r = 0.9, p<0.0001) between ceftiofur-resistant...
UNITED-STATES | INFECTIOUS DISEASES | INFECTIONS | STRIPS | RISK-FACTOR | BETA-LACTAMASE | NUGGETS | COMMENSAL ESCHERICHIA-COLI | EXTENDED-SPECTRUM CEPHALOSPORINS | IMMUNOLOGY | FOOD-PRODUCING ANIMALS | ANTIMICROBIAL RESISTANCE | Salmonella Food Poisoning - microbiology | Quebec - epidemiology | Humans | Drug Resistance, Bacterial | Chickens - microbiology | Poultry Diseases - drug therapy | Salmonella Food Poisoning - epidemiology | Salmonella Infections, Animal - epidemiology | Microbial Sensitivity Tests | Salmonella enterica - drug effects | Anti-Bacterial Agents | Animals | Canada - epidemiology | Salmonella Infections, Animal - microbiology | Salmonella Food Poisoning - drug therapy | Salmonella Infections, Animal - drug therapy | Cephalosporins - pharmacology | Meat - microbiology | Poultry Diseases - epidemiology | Moxalactam | Drug resistance in microorganisms | Salmonella | Noise control | Printing industry | Contamination | Risk factors | Cephalosporins | Water quality | Horses | Cephaloridine | Beta lactamases | Public health | chickens | Canada | bacteria | expedited | antimicrobial resistance | Escherichia coli | Salmonella enterica serovar Heidelberg | Research | humans
UNITED-STATES | INFECTIOUS DISEASES | INFECTIONS | STRIPS | RISK-FACTOR | BETA-LACTAMASE | NUGGETS | COMMENSAL ESCHERICHIA-COLI | EXTENDED-SPECTRUM CEPHALOSPORINS | IMMUNOLOGY | FOOD-PRODUCING ANIMALS | ANTIMICROBIAL RESISTANCE | Salmonella Food Poisoning - microbiology | Quebec - epidemiology | Humans | Drug Resistance, Bacterial | Chickens - microbiology | Poultry Diseases - drug therapy | Salmonella Food Poisoning - epidemiology | Salmonella Infections, Animal - epidemiology | Microbial Sensitivity Tests | Salmonella enterica - drug effects | Anti-Bacterial Agents | Animals | Canada - epidemiology | Salmonella Infections, Animal - microbiology | Salmonella Food Poisoning - drug therapy | Salmonella Infections, Animal - drug therapy | Cephalosporins - pharmacology | Meat - microbiology | Poultry Diseases - epidemiology | Moxalactam | Drug resistance in microorganisms | Salmonella | Noise control | Printing industry | Contamination | Risk factors | Cephalosporins | Water quality | Horses | Cephaloridine | Beta lactamases | Public health | chickens | Canada | bacteria | expedited | antimicrobial resistance | Escherichia coli | Salmonella enterica serovar Heidelberg | Research | humans
Journal Article
Canadian Journal of Microbiology, ISSN 0008-4166, 12/2013, Volume 59, Issue 12, pp. 778 - 788
The introduction of the 7-valent pneumococcal vaccine (PCV7) in Canada was very effective in reducing invasive pneumococcal disease (IPD) in children; however,...
Invasive pneumococcal disease | Pcv13 | Serotype | Surveillance | Streptococcus pneumoniae | UNITED-STATES | PCV13 | INFECTIONS | MICROBIOLOGY | invasive pneumococcal disease | ANTIMICROBIAL RESISTANCE | CHILDREN | REPLACEMENT | CHANGING EPIDEMIOLOGY | IMMUNIZATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DISEASE | surveillance | ASSOCIATION | serotype | Streptococcus pneumoniae - classification | Streptococcus pneumoniae - drug effects | Humans | Middle Aged | Vaccination | Child, Preschool | Infant | Male | Pneumococcal Vaccines - administration & dosage | Incidence | Young Adult | Anti-Bacterial Agents - therapeutic use | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Canada - epidemiology | Adolescent | Pneumococcal Infections - prevention & control | Adult | Female | Pneumococcal Infections - microbiology | Anti-Bacterial Agents - pharmacology | Child | Infant, Newborn | Serotyping | Prevention | Invasive species | Pneumonia | Bacterial pneumonia | Dosage and administration | Research | Vaccines | Antibacterial agents
Invasive pneumococcal disease | Pcv13 | Serotype | Surveillance | Streptococcus pneumoniae | UNITED-STATES | PCV13 | INFECTIONS | MICROBIOLOGY | invasive pneumococcal disease | ANTIMICROBIAL RESISTANCE | CHILDREN | REPLACEMENT | CHANGING EPIDEMIOLOGY | IMMUNIZATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DISEASE | surveillance | ASSOCIATION | serotype | Streptococcus pneumoniae - classification | Streptococcus pneumoniae - drug effects | Humans | Middle Aged | Vaccination | Child, Preschool | Infant | Male | Pneumococcal Vaccines - administration & dosage | Incidence | Young Adult | Anti-Bacterial Agents - therapeutic use | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Canada - epidemiology | Adolescent | Pneumococcal Infections - prevention & control | Adult | Female | Pneumococcal Infections - microbiology | Anti-Bacterial Agents - pharmacology | Child | Infant, Newborn | Serotyping | Prevention | Invasive species | Pneumonia | Bacterial pneumonia | Dosage and administration | Research | Vaccines | Antibacterial agents
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 07/2017, Volume 65, Issue 1, pp. 37 - 45
Background. Increasing azithromycin usage and resistance in Neisseria gonorrhoeae threatens current dual treatment. Because antimicrobial exposure influences...
whole genome sequencing | treatment | azithromycin | Neisseria gonorrhoeae | antimicrobial resistance | DIAGNOSIS | INFECTIOUS DISEASES | EUROPEAN GUIDELINE | MANAGEMENT | CANADA | MICROBIOLOGY | IMMUNOLOGY | THERAPY | MUTATION | RESISTANCE | INFECTIOUS-DISEASES-SOCIETY | Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Humans | Male | Gonorrhea - drug therapy | Azithromycin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Genome, Bacterial - genetics | Azithromycin - therapeutic use | Molecular Epidemiology | Adult | Female | Anti-Bacterial Agents - pharmacology | Retrospective Studies | Drug Resistance, Bacterial - drug effects | Genome, Bacterial - drug effects | Gonorrhea - epidemiology
whole genome sequencing | treatment | azithromycin | Neisseria gonorrhoeae | antimicrobial resistance | DIAGNOSIS | INFECTIOUS DISEASES | EUROPEAN GUIDELINE | MANAGEMENT | CANADA | MICROBIOLOGY | IMMUNOLOGY | THERAPY | MUTATION | RESISTANCE | INFECTIOUS-DISEASES-SOCIETY | Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Humans | Male | Gonorrhea - drug therapy | Azithromycin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Genome, Bacterial - genetics | Azithromycin - therapeutic use | Molecular Epidemiology | Adult | Female | Anti-Bacterial Agents - pharmacology | Retrospective Studies | Drug Resistance, Bacterial - drug effects | Genome, Bacterial - drug effects | Gonorrhea - epidemiology
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 7, pp. 1960 - 1964
Objectives: Serotype replacement in Streptococcus pneumoniae following the implementation of a new vaccine has been associated with the emergence of...
Antimicrobial drug resistance | S. pneumoniae | Non-PCV-13 serotypes | Multilocus sequence typing | MLST | antimicrobial drug resistance | multilocus sequence typing | PNEUMOCOCCAL CONJUGATE VACCINE | INFECTIOUS DISEASES | non-PCV-13 serotypes | PILUS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | EPIDEMIOLOGY | Streptococcus pneumoniae - classification | Streptococcus pneumoniae - drug effects | Prevalence | Virulence Factors - genetics | Humans | Virulence | Serogroup | Genotype | Molecular Typing | Microbial Sensitivity Tests | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Canada - epidemiology | Fimbriae Proteins - genetics | Drug Resistance, Multiple, Bacterial | Pneumococcal Vaccines - immunology | Pneumococcal Infections - microbiology
Antimicrobial drug resistance | S. pneumoniae | Non-PCV-13 serotypes | Multilocus sequence typing | MLST | antimicrobial drug resistance | multilocus sequence typing | PNEUMOCOCCAL CONJUGATE VACCINE | INFECTIOUS DISEASES | non-PCV-13 serotypes | PILUS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | EPIDEMIOLOGY | Streptococcus pneumoniae - classification | Streptococcus pneumoniae - drug effects | Prevalence | Virulence Factors - genetics | Humans | Virulence | Serogroup | Genotype | Molecular Typing | Microbial Sensitivity Tests | Pneumococcal Infections - epidemiology | Streptococcus pneumoniae - isolation & purification | Canada - epidemiology | Fimbriae Proteins - genetics | Drug Resistance, Multiple, Bacterial | Pneumococcal Vaccines - immunology | Pneumococcal Infections - microbiology
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A284
BackgroundWhole genome sequencing (WGS) is a high-resolution approach for tracking the transmission and antimicrobial susceptibility (AMS) of Neisseria...
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 12/2019, Volume 19, Issue 12, pp. 1284 - 1285
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 07/2017, Volume 23, Issue 7, pp. 1092 - 1101
The incidence of group C and G Streptococcus (GCGS) bacteremia, which is associated with severe disease and death, is increasing. We characterized clinical...
MORTALITY | DYSGALACTIAE SUBSP EQUISIMILIS | INFECTIOUS DISEASES | SCORE | BACTEREMIA | SEQUENCE | DISEASE | BETA-HEMOLYTIC STREPTOCOCCI | TOXIC-SHOCK-SYNDROME | GROUP-A | IMMUNOLOGY | STRAIN | Virulence Factors - genetics | History, 21st Century | Humans | Middle Aged | Child, Preschool | Infant | Male | Phylogeny | Multilocus Sequence Typing | Streptococcus - pathogenicity | Young Adult | Streptococcus - classification | Streptococcus - isolation & purification | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Infant, Newborn | Severity of Illness Index | Streptococcal Infections - microbiology | Genome, Bacterial | Comorbidity | Manitoba - epidemiology | Streptococcal Infections - epidemiology | Streptococcal Infections - history | Whole Genome Sequencing | Streptococcal Infections - diagnosis | Streptococcus - genetics | Adolescent | Aged | Polymorphism, Single Nucleotide | Cluster Analysis | Genomes | Health aspects | Analysis | Genomics | Clonal Clusters and Virulence Factors of Group C and G | Canada | bacteria | invasive disease | Streptococcus dysgalactiae | genome sequencing | virulence factor | Research | Causing Severe Infections, Manitoba, Canada, 2012–2014 | group G Streptococcus | group C Streptococcus | bacteremia | group C streptococci | group G streptococci
MORTALITY | DYSGALACTIAE SUBSP EQUISIMILIS | INFECTIOUS DISEASES | SCORE | BACTEREMIA | SEQUENCE | DISEASE | BETA-HEMOLYTIC STREPTOCOCCI | TOXIC-SHOCK-SYNDROME | GROUP-A | IMMUNOLOGY | STRAIN | Virulence Factors - genetics | History, 21st Century | Humans | Middle Aged | Child, Preschool | Infant | Male | Phylogeny | Multilocus Sequence Typing | Streptococcus - pathogenicity | Young Adult | Streptococcus - classification | Streptococcus - isolation & purification | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Infant, Newborn | Severity of Illness Index | Streptococcal Infections - microbiology | Genome, Bacterial | Comorbidity | Manitoba - epidemiology | Streptococcal Infections - epidemiology | Streptococcal Infections - history | Whole Genome Sequencing | Streptococcal Infections - diagnosis | Streptococcus - genetics | Adolescent | Aged | Polymorphism, Single Nucleotide | Cluster Analysis | Genomes | Health aspects | Analysis | Genomics | Clonal Clusters and Virulence Factors of Group C and G | Canada | bacteria | invasive disease | Streptococcus dysgalactiae | genome sequencing | virulence factor | Research | Causing Severe Infections, Manitoba, Canada, 2012–2014 | group G Streptococcus | group C Streptococcus | bacteremia | group C streptococci | group G streptococci
Journal Article